Galera Therapeutics Stock (NASDAQ: GRTX) stock price, news, charts, stock research, profile.
Open | $0.180 |
Close | $0.208 |
Volume / Avg. | 678.947K / 1.977M |
Day Range | 0.176 - 0.210 |
52 Wk Range | 0.085 - 3.590 |
Market Cap | $11.314M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 4.41% |
Days to Cover | 1.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galera Therapeutics (NASDAQ: GRTX) through any online brokerage.
Other companies in Galera Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Galera Therapeutics (NASDAQ: GRTX) was reported by Citigroup on Tuesday, August 29, 2023. The analyst firm set a price target for 0.25 expecting GRTX to rise to within 12 months (a possible 20.19% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Galera Therapeutics (NASDAQ: GRTX) is $0.208 last updated Today at April 25, 2024 at 5:53 PM EDT.
There are no upcoming dividends for Galera Therapeutics.
Galera Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Galera Therapeutics.
Galera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.